| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/17/2012 | US8097250 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 01/17/2012 | US8097244 Human prostate cell lines in cancer treatment |
| 01/17/2012 | US8097238 Cell targeting conjugates |
| 01/17/2012 | CA2604357C P-cadherin antibodies |
| 01/17/2012 | CA2501220C Vaccines against west nile virus |
| 01/17/2012 | CA2457362C Human monoclonal rabies virus neutralizing antibodies, and methods for making and using the same |
| 01/17/2012 | CA2451353C Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 01/17/2012 | CA2446390C Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 01/17/2012 | CA2345208C Protective recombinant haemophilus influenzae high molecular weight proteins |
| 01/17/2012 | CA2264191C Recombinant toxin fragments |
| 01/17/2012 | CA2211147C A method of preparing an undifferentiated cell |
| 01/17/2012 | CA2148712C Peripheralization of hematopoietic stem cells |
| 01/12/2012 | WO2012006634A2 Prostate specific antigen (psa) peptide therapy |
| 01/12/2012 | WO2012006552A1 Combinations of kinase inhibitors for the treatment of cancer |
| 01/12/2012 | WO2012006550A2 Methods and compositions for treatment of lipogenic virus related conditions |
| 01/12/2012 | WO2012006500A2 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | WO2012006490A2 Dual variable domain immunoglobulins and uses thereof |
| 01/12/2012 | WO2012006395A1 Respiratory syncytial virus antigenic compositions and methods |
| 01/12/2012 | WO2012006378A1 Liposomes with lipids having an advantageous pka- value for rna delivery |
| 01/12/2012 | WO2012006376A2 Virion-like delivery particles for self-replicating rna molecules |
| 01/12/2012 | WO2012006368A2 Compositions and methods for treating influenza |
| 01/12/2012 | WO2012006367A2 Compositions and methods for treating influenza |
| 01/12/2012 | WO2012006342A2 Ceramide-like glycolipid-associated bacterial vaccines and uses thereof |
| 01/12/2012 | WO2012006220A1 Treatment of avian species with inhibitors of p110 delta signaling |
| 01/12/2012 | WO2012006180A1 Hiv immunogens |
| 01/12/2012 | WO2012005732A1 Designer peptide-based pcv2 vaccine |
| 01/12/2012 | WO2012005550A2 Pharmaceutical composition for treating gallbladder carcinoma, and method for inhibiting growth and metastasis of gallbladder carcinoma and treating gallbladder carcinoma, using same |
| 01/12/2012 | WO2012005328A1 Antibody capable of binding to lysophosphatidylglucoside, and composition containing the antibody |
| 01/12/2012 | WO2012005161A1 Cancer peptide vaccine |
| 01/12/2012 | WO2012004773A1 New uses of nogo-a inhibitors and related methods |
| 01/12/2012 | WO2012004645A1 A RECOMBINANT VACCINE AGAINST CLOSTRIDIUM PERFRINGENS INFECTION AND EPSILON (ε) TOXIN INTOXICATION |
| 01/12/2012 | WO2012004410A1 B7-h3 antagonists and taxanes |
| 01/12/2012 | WO2012003956A1 Cancer therapy using cldn6 target-directed antibodies in vivo |
| 01/12/2012 | WO2012003814A1 Vaccine compositions based on sticholysin encapsulated in liposomes |
| 01/12/2012 | WO2011153590A8 Use of interferon epsilon in methods of diagnosis and treatment |
| 01/12/2012 | WO2011145629A3 ANTIBODY CAPABLE OF BINDING TO TRANSFORMING GROWTH FACTOR ALPHA AND HAVING ANTIPROLIFERATIVE ACTIVITY ON CANCER HAVING Ras GENE MUTATION |
| 01/12/2012 | WO2011133919A4 Use of tau to monitor immunotherapy |
| 01/12/2012 | WO2011129427A9 Diagnostic agent and therapeutic agent for cancer |
| 01/12/2012 | WO2011116353A3 Method for regulating survival and memory of t helper 1 cells |
| 01/12/2012 | WO2011106525A9 Methods of treating cerebral amyloid angiopathy |
| 01/12/2012 | WO2011068934A4 Vaccine against neoplastic or cancerous lesions caused by human papillomavirus (hpv), procedures, uses and methods |
| 01/12/2012 | WO2002036070A3 Novel fish chemokine and methods for use |
| 01/12/2012 | US20120010599 Inorganically surface-modified polymers and methods for making and using them |
| 01/12/2012 | US20120010557 Drug Delivery System for Use in the Treatment of Vascular and Vessel-Related Pathologies |
| 01/12/2012 | US20120010384 Epitope synchronization in antigen presenting cells |
| 01/12/2012 | US20120009654 Monoparamunity inducers based on attenuated rabbit myxomaviruses |
| 01/12/2012 | US20120009648 DNA polymerase lambda and uses thereof |
| 01/12/2012 | US20120009254 Respiratory Syncytial Virus Antigenic Compositions and Methods |
| 01/12/2012 | US20120009248 Preservation of Bioactive Materials By Spray Drying |
| 01/12/2012 | US20120009247 Phospholipid drug analogs |
| 01/12/2012 | US20120009221 Transfection of blood cells with mrna for immune stimulation and gene therapy |
| 01/12/2012 | US20120009220 Low Antigen-dose Immunization for Maximizing T-helper Cell 1 (Th1) Immunity Against a Pathogen |
| 01/12/2012 | US20120009219 Bacillus anthracis protective antigen sequences |
| 01/12/2012 | US20120009218 Attenuated Gram Negative Bacteria |
| 01/12/2012 | US20120009217 Monoparamunity inducers based on attenuated rabbit myxomaviruses |
| 01/12/2012 | US20120009216 Early detection of flaviviruses using the ns1 glycoprotein |
| 01/12/2012 | US20120009215 Influenza hemagglutinin and neuraminidase variants |
| 01/12/2012 | US20120009214 Intergenic regions as novel sites for insertion of hiv dna sequences in the genome of modified vaccinia virus ankara |
| 01/12/2012 | US20120009213 Meningococcal And Pneumococcal Conjugate Vaccine And Method Of Using Same |
| 01/12/2012 | US20120009212 Conjugates utilizing platform technology for stimulating immune response |
| 01/12/2012 | US20120009211 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 01/12/2012 | US20120009210 Hypallergenic mosaic antigens and methods of making same |
| 01/12/2012 | US20120009209 Enrichment and purification of infectious prion proteins |
| 01/12/2012 | US20120009208 USE OF MEMBRANE ATTACK COMPLEX (MAC) AND IMMUNE COMPLEXES (ICs) TO ACTIVATE T-CELLS AND THE GENERATION OF REGULATORY T CELLS |
| 01/12/2012 | US20120009206 Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity |
| 01/12/2012 | US20120009205 Modified Fc Molecules |
| 01/12/2012 | US20120009204 Treatment of Metastatic Breast Cancer |
| 01/12/2012 | US20120009203 Depletion of cancer stem cells |
| 01/12/2012 | US20120009202 Target host factors for treating viral infection |
| 01/12/2012 | US20120009201 Renal cell carcinoma biomarkers |
| 01/12/2012 | US20120009200 Fibroblast growth factor receptor-3 (fgfr-3) inhibitors and methods of treatment |
| 01/12/2012 | US20120009199 Antibody formulations |
| 01/12/2012 | US20120009198 Compositions and Methods for Modulating Immune Response |
| 01/12/2012 | US20120009197 Anti-Human Equilibrative Nucleoside Transporter 1 (hENT1) Antibodies and Methods of Use Thereof |
| 01/12/2012 | US20120009196 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | US20120009195 Antibody neutralizers of human granulocyte macrophage colony stimulating factor |
| 01/12/2012 | US20120009194 Antibodies to endoplasmin and their use |
| 01/12/2012 | US20120009193 Method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same |
| 01/12/2012 | US20120009192 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| 01/12/2012 | US20120009191 Methods of treating bone-loss disorders using a gm-csf antagonist |
| 01/12/2012 | US20120009190 Identification and method for using the pre-ligand assembly domain of the il-17 receptor |
| 01/12/2012 | US20120009189 Antibody composition with altered fab sialylation |
| 01/12/2012 | US20120009188 Optimized fc variants |
| 01/12/2012 | US20120009187 Cloning and recombinant productions of vespula venom protease and methods of use thereof |
| 01/12/2012 | US20120009186 FcGammaRIIB Specific Antibodies and Methods of Use Thereof |
| 01/12/2012 | US20120009185 Method for treating age-related macular degeneration |
| 01/12/2012 | US20120009184 Anti-C5 Alpha Antibodies |
| 01/12/2012 | US20120009183 Method for treatment of pancreatitis |
| 01/12/2012 | US20120009182 Immunoglobulin variants with altered binding to protein a |
| 01/12/2012 | US20120009181 Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof |
| 01/12/2012 | US20120009180 Anti-abeta oligomer humanized antibody |
| 01/12/2012 | US20120009179 ANTI-Aß OLIGOMER HUMANIZED ANTIBODY |
| 01/12/2012 | US20120009178 Tweak binding antibodies |
| 01/12/2012 | US20120009177 Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment |
| 01/12/2012 | US20120009151 Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof |
| 01/12/2012 | US20120009149 Tetrameric Cytokines with Improved Biological Activity |
| 01/12/2012 | US20120009146 Treatment and Diagnostic Methods for Fibrosis Related Disorders |
| 01/12/2012 | US20120009145 Biodegradable Cross-Linked Cationic Multi-block Copolymers for Gene Delivery and Methods of Making Thereof |
| 01/12/2012 | US20120009141 Functionalized pyrrolidines and use thereof as iap inhibitors |
| 01/12/2012 | US20120009140 Compostition and therapeutic anti-tumour vaccine |